Viewing Study NCT06406634

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:26 AM
Ignite Modification Date: 2026-02-10 @ 9:31 AM
Study NCT ID: NCT06406634
Status: RECRUITING
Last Update Posted: 2024-05-09
First Post: 2024-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Sponsor: Hunan Cancer Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cadonilimab View
None Lenvatinib View
None Hepatic Arterial Infusion Chemotherapy (HAIC) View
None Unresectable Hepatocellular Carcinoma View